Xeris Biopharma Holdings
XERS
XERS
103 hedge funds and large institutions have $82.4M invested in Xeris Biopharma Holdings in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 103 → 103 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
36% less capital invested
Capital invested by funds: $128M → $82.4M (-$46.1M)
Holders
103
Holding in Top 10
2
Calls
$2.68M
Puts
$208K
Top Buyers
| 1 | +$9.26M | |
| 2 | +$5.73M | |
| 3 | +$2.67M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.67M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.56M |
Top Sellers
| 1 | -$2.81M | |
| 2 | -$1.36M | |
| 3 | -$1.13M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.04M |
| 5 |
Goldman Sachs
New York
|
-$942K |